Home > Latest NewsLatest News
The content below contains the latest news affecting community pharmacy owners and their teams throughout Scotland. If you can’t find something or you have a question please get in touch with us at webteam@cps.scot
PCA(P)(2024)11 - Extension to SSP for Clarithromycin 125mg/ml and 250mg/ml Oral Suspension
This Circular advises community pharmacy contractors that the two UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin antibiotic products due to expire on 21 June 2024 have now been extended until Friday 19 July 2024.
PCA(P)(2024)09 - Reactivation of SSP for Clarithromycin 125mg/5ml and 250mg/5ml Oral Suspension
This Circular advises Health Boards and community pharmacy contractors that the two UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin 125mg/5ml and 250mg/5ml oral suspension have been reactivated on 22 May 2024. The new end date for both SSPs is now 21 June 2024.
PCA(P)(2024)08 - SSP: Creon® 25000 Gastro-Resistant Capsules
To advise of a Serious Shortage Protocol (SSP) in place for Creon® 25000 gastro-resistant capsules, from 24 May 2024 to 22 November 2024.
PCA(P)(2024)07 - Serious Shortage Protocol: Creon® 10000 Gastro-Resistant Capsules
To advise of a Serious Shortage Protocol (SSP) in place for Creon® 10000 gastro-resistant capsules, from 24 May 2024 to 22 November 2024.
PCA(P)(2024)05 - Extension to SSP for Isosorbide Mononitrate
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for isosorbide mononitrate (Monomil® XL) 60mg modified release tablet due to expire on 3 May 2024 has been extended until Friday 31 May 2024.
PCA(P)(2024)03 - Serious Shortage Protocol for Isosorbide Mononitrate (Monomil XL) 60mg Modified Release Tablet
To advise of a Serious Shortage Protocol (SSP) in place for isosorbide mononitrate (Monomil® XL) 60mg modified release tablet, from 26 March 2024 to 3 May 2024.
PCA(P)(2023)43 - Extension to SSP for Clarithromycin
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for Clarithromycin
PCA(P)(2023)41 - SSP for Issued for Clarithromycin
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for Clarithromycin
PCA(P)(2023)40 - Extension to SSP issued for Estradot®
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Estradot®
PCA(P)(2023)38 - Extension to SSP for Jext 300 micrograms/ 0.3mL
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Jext® 300 micrograms/ 0.3mL (1 in 1000) solution for injection auto-injector pen
PCA(P)(2023)37 - SSP for Estradot® 100 Microgram Patches
This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Estradot® (estradiol hemihydrate) 100 microgram patches
PCA(P)(2023)36 - SSP for Clarithromycin
This Circular advises community pharmacy contractors that two of the UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin antibiotic
PCA(P)(2023)33 - SSP for Estradot®
This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Estradot® (estradiol hemihydrate) 100 microgram patches
PCA(P)(2023)32 - SSP for Utrogestan®
This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Utrogestan®
PCA(P)(2023)31 - SSP for Jext 300 micrograms/0.3mL
To advise of a Serious Shortage Protocol (SSP) in place for Jext® 300 micrograms/0.3mL (1 in 1000) solution for injection auto-injector pen, from 21 August 2023 to 15 September 2023.
PCA(P)(2023)30 - SSP for Estradot (Estradiol hemihydrate)
To advise of a Serious Shortage Protocol (SSP) in place for Estradot® (Estradiol hemihydrate) 100 microgram patches, from 21 August 2023 to 8 September 2023.
PCA(P)(2023)29 - SSP for Progynova®
This Circular advises community pharmacy contractors that the Serious Shortage Protocol (SSP) for Progynova®
PCA(P)(2023)28 - Extension to SSP for Utrogestan® 100mg Capsules
This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Utrogestan® (micronised progesterone) 100mg capsules
PCA(P)(2023)25 - Extension to SSP for Clarithromycin Antibiotic
Two of the UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin antibiotic products due to expire on 21 July 2023 have now been extended
PCA(P)(2023)24 - Extension to SSP issued for Progynova TS
The UK-wide active Serious Shortage Protocol (SSP) for Progynova® (estradiol) TS 100 microgram patches, a hormone replacement therapy (HRT)